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Abstract
Human papillomavirus (HPV) infection, and in particularly infection with HPVs 16 and 18, is a central carcinogenic
factor in the uterine cervix. We established and optimized a PCR assay for the detection and discrimination of HPV
types 16 and 18 in archival formaldehyde fixed and paraffin embedded (FFPE) sections of cervical cancer.
Tissue blocks from 35 cases of in situ or invasive cervical squamous cell carcinoma and surrogate FFPE sections
containing the cell lines HeLa and SiHa were tested for HPV 16 and HPV18 by conventional PCR using type specific
primers, and for the housekeeping gene b-actin. Using HPV 16 E7 primers, PCR products with the expected length
were detected in 18 of 35 of FFPE sections (51%). HPV 18 E7 specific sequences were detected in 3 of 35 FFPE sec-
tions (9%).
In our experience, the PCR technique is a robust, simple and sensitive way of type specific detection of HPV16 and
HPV18 genes in FFPE tissue. That makes this technique applicable to routine practices of HPV detection.
Findings
Human papillomavirus (HPV) infection is a central car-
cinogenic factor in the uterine cervix, and cervix cancer
is a common malignancy in women worldwide [1]. Most
women with squamous epithelial dysplasia or invasive
squamous cell carcinoma of the cervix are infected with
high risk HPV types, particularly HPVs 16 and 18 [2,3].
HPV E6 and E7 oncoproteins interfere with the function
of the tumor suppressor proteins p53 and pRB, leading
to hyperproliferation and genomic instability [2,4,5].
The new vaccination program should confer type spe-
cific immunity against HPV 16 and 18, and it is
expected to be a valuable tool for reducing the incidence
of cervical cancer [6]. To evaluate the efficacy of vacci-
nation, it is useful to determine the HPV types found in
routine cervical samples from vaccinated persons.
In the present study we aimed to establish sensitive,
specific and simple assays for type specific detection of
t h ep r e s e n c eo ft h eE 7r e g i o no fH P V1 6a n d1 8D N A
in FFPE tissue, since fresh unfixed tissue is rarely avail-
able for routine diagnostics. Methods to this end, such
as HPV detection by PCR using the MY09/MY11 and
GP5+/GP6+ primer systems have been described, but
have often been found to allow only the broad detection
of a spectrum of HPVs [7,8]. A number of PCR based
detection methods of high risk HPV in unfixed sections
have been reported, but only a few reports on PCR
detection of HPV in FFPE cervical cancer sections exist
[9]. Thus we desired to create a more robust type speci-
f i cd e t e c t i o n-s or o b u s tt h a ti tw o u l de v e nw o r ko n
FFPE material.
In general the sensitivity of PCR-based assays is lower
in FFPE specimens compared with fresh, unfixed tissues
as a result of degradation and fragmentation of the tar-
get DNA [10-12]. Typically, DNA sequences extracted
from FFPE tissues are found in fragments with a length
of 200 bp or less [10,12,13].
Tissue blocks from 35 cases of loop excision or surgical
excision of carcinoma in situ or of invasive cervical squa-
mous carcinoma were randomly selected in the pathology
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Institute of Pathology, Aarhus University Hospital. All
were routine diagnostic surgical specimens that had been
fixed in buffered formalin and embedded in paraffin. Spe-
cific fixation times were not known for individual speci-
mens, but typically varied between 18 and 24 hours. Cases
were classified on haematoxylin and eosin stained sections
by a pathologist experienced in evaluation of gynaecologi-
cal pathology according to standard World Health Organi-
zation diagnostic criteria
We used the following cell lines as controls in our
study: HeLa (contains about 50 copies of HPV 18
according to the supplier), SiHa (contains 2-5 copies of
HPV 16 according to the supplier) and fetal kidney cell
line 293-EBNA (does not contain HPV) [14]. Cell lines
cells were fixed in 4% buffered formaldehyde pH-7
(VWR international Geldenaaksenbaan 464, B-3001 Leu-
ven Belgium), centrifuged, and the cell pellets were
embedded in paraffin in order to simulate the routine
fixation procedure.
DNA isolation from unfixed Hela, SiHa and 293-
EBNA cell lines was performed using a QIAmp DNA
purification kit (QIAGEN, http://www.qiagen.com)
according to the manufacturer’s protocol.
DNA isolation from FFPE tissue was performed the
following way: three 15 μm paraffin sections were cut
from each FFPE specimen and placed in an eppendorf
tube. In order to prevent cross-contamination, a new
microtome blade was used for each specimen. Sections
were deparaffinized by incubation for 2 × 20 min at 60°
C in Tissue-Clear (Sakura Finetek Europe, 2382 AT,
Zoeterwoude, NL), then placed in 99% ethanol for 2 ×
20 min at 60°C and air-dried. They were subsequently
resuspended in 300 μl of digestion buffer (50 mM Tris-
HCl [pH 7.5], 10 mM EDTA, 0.5% sodium dodecyl sul-
fate, 50 mM NaCl, and 1.5 mg/ml proteinase K [Roche,
Basel, Switzerland]) and incubated at 56°C under rock-
ing conditions for 24 hours until the tissue was comple-
tely digested. The proteinase K was inactivated by
incubating the samples for 20 min at 95°C. Phenol/
chloroform/isoamyl alcohol (25:24:1; v/v) was added to
each tube at a volume equal to that of the digestion
mixture (300 μl). Tubes were then vortexed for 10-15
sec and centrifuged at 14,000 rpm for 5 min. The super-
natant was transferred to new tubes and mixed with 1/
10 volume of 3 M sodium acetate and 2.5 volume of
99% ice-cold ethanol, incubated at -20°C for 30 min,
then centrifuged at 14,000 rpm for 5 min, and the
supernatant was discarded. Pellets were washed with 1
ml of 70% ethanol, centrifuged for 5 min at 14,000 rpm,
after which the ethanol was removed and the specimen
air-dried. Dry pellets were then resuspended in water.
The integrity and purity of the DNA extraction and the
concentration of the extracted DNA was assessed by
spectrophotometry.
DNA extracted from unfixed cells and from FFPE sec-
tions was used as template for PCR reactions. Amplifica-
tion reactions were performed with an AmpliTaq Gold
PCR kit (Applied Biosystems, CA). The reaction mixture
with a total volume of 25 μL contained 1 × AmpliTaq
Gold buffer, 5.5 mM MgCl2, 100 nM of each dNTP, 300
nM of each primers, and 0.6 U AmpliTaq Gold poly-
merase. The DNA template concentrations varied from
5 ng to 500 ng per reaction. The primers used for the
b-actin detection are listed in table 1. The amplification
was performed in two steps where 2.5 μLo ft h eP C R
product from step 1 was used as a template in step 2.
The PCR cycling conditions were 95°C 12 min, (60°C 1
min, 72°C 1 min, 95°C 30 sec) × 40 cycles, 72°C 1 min.
Ten μl of PCR product was run in 1.5% agarose gel at
80 V for 90 min and stained with ethidium bromide, to
demonstrate the expected PCR product length of 99 bp.
DNA extracted from both unfixed cells and FFPE sec-
tions was used as template for type specific HPV 16 and
HPV 18 detection. Amplification reactions were per-
formed with the FastStart High Fidelity PCR system
(Roche). Primers are listed in table 1, and gave an
expected PCR product length of 196 bp and 172 bp
respectively for HPV 16 and HPV 18. Reaction mixtures
with a total volume of 50 μl contained 1 × reaction buf-
fer without Mg
2+,3 . 0m MM g C l 2,2 0 0μM of each
dNTP, 0.4 μM of each primers, and 2.5 U FastStart
High Fidelity Taq polymerase. DNA template concentra-
tions varied from 5 ng to 500 ng per reaction. The
amplification was performed in two steps: PCR cycling
95°C 5 min, (95°C 30 sec, ramp from 57°C to 48°C, 1°C
per cycle, 72°C 1 min) 10 cycles, (95°C 30 sec, 48°C 30
sec, 72°C 1 min) × 25, 72°C 5 min. Ten μlo fP C Rp r o -
duct were run in 1.5% agarose gel at 80 V for 90 min
and stained with ethidium bromide.
To evaluate the quality of the DNA extracted from the
study specimens for amplification by PCR, all samples
were tested for the housekeeping gene b-actin using
PCR. b-actin DNA was detected in 32 of 35 (91%) FFPE,
in situ or invasive cervical squamous carcinoma samples
whereas b-actin was detected in all cell line samples
(table 2; figure 1). Negative controls were consistently
negative for b-actin.
All samples and controls were tested for HPV 16 E7
and HPV 18 E7 using specific primers within the E7
regions of the two genomes. Primers were designed
using the “Vector NTI” software. The HPV16, HPV18
and b-actin sequences were obtained from the NCBI
database. Results are shown in table 2. No amplification
products were seen in the 293-EBNA (HPV-negative)
cell line used as a negative control. The expected PCR
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mers in both unfixed and FFPE SiHa cell lines. In both
unfixed and FFPE HeLa cell lines, a PCR product of the
expected 172 bp length was detected using primers
complementary to the HPV 18 E7 region. We detected
no evidence of cross reactions between the HPV 16 E7
a n dt h eH P V1 8E 7r e g i o n s .U s i n gH P V1 6E 7p r i m e r s ,
PCR products with the expected length of 196 bp were
detected in 18 of 35 of FFPE sections (51%) (figure 2),
whereas HPV 18 E7 specific sequences were detected in
3 of 35 FFPE sections (9%) (figure 3).
We designed and optimized our PCR assay for the
detection of HPV in potentially damaged DNA tem-
plates. In accordance with previous studies showing that
PCR-based detection assays in FFPE sections work best
when the amplicon size is up to 200 bp, amplicon sizes
from 99 bp to 196 bp were used [11,15]. To validate the
suitability of each study block, DNA extracted from
FFPE sections was analyzed using PCR for the single
copy housekeeping gene b-actin. This gene could not be
detected in 3 of 35 specimens (9%) although in 2 of
these cases, specific HPV sequences could be amplified.
This suggests that our HPV targets were easier to detect
than the b-actin gene. This may reflect that the HPV
g e n e sa r ep r e s e n ti nt h et i s s u e si nm u l t i p l ec o p i e sp e r
cell, as compared with the single copy b-actin gene.
We chose to place the amplified region of HPV DNA
in the E7 regions of HPV DNA, as the expression of the
HPV 16 and HPV 18 oncogenes E6 and E7 shows a
strong positive correlation with the development of
invasive cervical carcinoma [4,5]. In order to improve
type specific detection of HPVs 16 and 18, we chose
PCR primers from gene regions with maximum
sequence difference between the two types of HPV. Our
method proved sensitive and specific for the HPV 16
and 18 types, as we detected the expected HPV positiv-
ity in both unfixed and surrogate FFPE tissues contain-
ing HeLa and SiHa cell lines with no cross reactions
between the two types of HPV.
Using HPV 16 E7 primers, PCR products were
detected in 51% of sections, whereas HPV 18 E7 specific
sequences were detected in 9% of sections. These fre-
quencies correspond with Zur-Hausen et al. who
reported that HPV 16 was found in approximately 50%
of all cervical cancer and HPV 18 in close to 20% [2,16].
We conclude that the yield and quality of the DNA
extracted from the archival FFPE sections of cervical
carcinoma was sufficient for PCR assays. Using our opti-
mized PCR protocol, we were able to specifically detect
Table 1 PCR primers used
Amplified region Primer Sequences Melting temperature Amplimer length
HPV16 E7 Pr. 591-620 5’ATA TAT GTT AGA TTT GCA ACC AGA GAC AAC 3’ 55.9°C 196 bp
Pr. 786-762 5’GTC TAC GTG TGT GCT TTG TAC GCA C 3’ 54.2°C
HPV18 E7 Pr. 533-553 5’CCG AGC ACG ACA GGA GAG GCT 3’ 60.3°C 172 bp
Pr. 705-682 5’ TCG TTT TCT TCC TCT GAG TCG CTT 3’ 57.5°C
b-actin Pr. 6999-7018 5’CCACACTGTGCCCATCTACG3’ 53.6°C 99 bp
Pr. 7097-7072°C 5’AGGATCTTCATGAGGTAGTCAGTCAG3’ 54.0°C
Figure 1 Analysis of the b-actin housekeeping gene in FFPE
sections of cervical cancer (lanes 1-12). Following PCR, products
were electrophoresed in 1.5% agarose gel (amplicon length 99 bp).
Figure 2 Analysis of HPV 16 E7 in FFPE material. Following PCR,
products were electrophoresed in 1.5% agarose gel (amplicon
length 196 bp). Lane 1 represents positive control DNA (from HPV-
16 positive SiHa cell line); lane 2 is a negative control (no template);
a lane 3-21 represents DNA from FFPE sections of cervical cancer.
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specimens with a simple, reproducible and cheap
method.
The assay could be applied for post-vaccination typing
of HPV types where a universal PCR for HPV identifies
any HPV infection, whereas this assay identifies the sub-
population of infections caused by HPV 16 and 18.
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